In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Clearside Biomedical Inc. Trade Record

NASDAQ:CLSD Clearside Biomedical Inc stock gains 89.33% Exit Mar 22, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart CLSD Feb 26, 2018, priceSeries
About Clearside Biomedical Inc

Clearside BioMedical, Inc., a biopharmaceutical company, develops drug therapies to treat chronic blinding diseases of the eye. Its products include CLS-1001 for the treatment of macular edema associated with non-infectious uveitis; CLS-1003 for the treatment of macular edema associated with retinal vein occlusion; and CLS-1002 program for the treatment of wet age-related macular degeneration. The company was founded in 2011 and is headquartered in Alpharetta, Georgia.

Trade Information
Trade Type
LONG
ReliabilityScore™
99.60
Entry Date
Feb 26, 2018
Entry Price
6.23
Sell Date
Mar 22, 2018
Sell Price
11.79
Net Gain
89.33%
Hold Time
18 Trading Days